US

Schlafman joins Primary Venture Partners as venture partner

New York City-based venture firm Primary Venture Partners has hired Steve Schlafman as venture partner. Previously, Schlafman worked at RRE Ventures and Lerer Hippeau.

Honest Buildings seals $5 mln

New York City-based Honest Buildings, a project management platform for real estate owners, has raised $5 million in funding. First Capital Realty led the round.

Kneron garners $18 mln

Kneron, a provider of edge artificial intelligence solutions, has raised $18 million in funding. The lead investor was Horizons Ventures.

CyberInt fetches $18 mln in Viola Growth-led round

CyberInt, an Israeli cybersecurity detection and response services company, has secured $18 million in financing. Viola Growth led the round.

Automotive tech company Protean Electric rallies $40 mln

Protean Electric, an automotive technology company, has raised $40 million in funding. The investor group was led by Weifu High-Technology Group Co Ltd and Oak Investment Partners.

ConDati pockets $4.75 mln Series A

Palo Alto, California-based ConDati, a provider of next-generation analytics for digital marketing, has raised $4.75 million in Series A funding. The investors were not named.

Online dating app Coffee Meets Bagel books $12 mln Series B

Coffee Meets Bagel, an online dating app, has raised $12 million in Series B funding. Atami Capital led the round with participation from other investors that included GingerBread Capital, DCM Ventures, Wi Harper and Quest Venture Partners.

Nova Credit collects $16 mln Series A

San Francisco-based Nova Credit, a consumer reporting company, has raised $16 million Series A financing, according to a blog post. The investors included General Catalyst.

Signifyd nabs $100 mln Series D

San Jose, California-based Signifyd, a provider of guaranteed fraud protection for e-commerce businesses, has secured $100 million in Series D funding. Premji Invest led the round with participation from return backers Bain Capital Ventures, Menlo Ventures, American Express Ventures, IA Ventures, Allegis Cyber and Resolute Ventures.

Cortexyme racks up $76 mln Series B

South San Francisco-based Cortexyme Inc, a developer of drugs focused on treating Alzheimer’s disease and other degenerative diseases, has closed $76 million in Series B funding. The investors included Sequoia Capital, Vulcan Capital, Verily Life Sciences, EPIQ Capital Group, RSL Investments, Huizenga Capital, Pfizer, Takeda Ventures, Lamond Family, Breakout Ventures and Dolby Family Ventures.